Ziprasidone formulations
US6150366A · kind A · utility
44Cited by
8References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 1999 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | May 27, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 .mu.m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.